Medicine Recalls

Follow the links below to find information about medicine recalls.

Updated November 2007

Printer friendly page

19 Resources Found
Results 1 to 19 displayed.
Title:   Safety alerts and advisory statements
Publisher:   Australian Government Department of Health and Ageing
Description:   Links to safety alerts and advisory statements about medicines and medical devices in Australia.
Date:   Aug 2008
Title:   Report a problem with a therapeutic product
Publisher:   Australian Government Department of Health and Ageing
Description:   Links to forms and information for reporting problems with therapeutic goods in Australia.
Date:   Jul 2008
Title:   Media release. Prudent measures to conserve anti-coagulant medicines
Publisher:   Australian Government Department of Health and Ageing
Description:   Guidelines for clinicians on prudent measures to manage a potential shortage of anti-coagulant medicines containing the blood thinning agent, heparin, have been issued.
Date:   May 2008
Title:   Product recalls
Publisher:   Australian Government Department of Health and Ageing
Description:   Links to consumer-level product recall notices issued by the Therapeutic Goods Administration.
Date:   Apr 2008
Title:   Trasylol (aprotinin) injection
Publisher:   Australian Government Department of Health and Ageing
Description:   On 6 November 2007, Bayer Australia Ltd announced a worldwide suspension of the supply of Trasylol (aprotinin) injection.
Date:   Nov 2007
Title:   Health alert: recall of Lida Daidaihua Slimming Capsules
Publisher:   Australian Government Department of Health and Ageing
Description:   A South Australian company, Mekong Grocery, upon instructions from Australia's medicines regulator, the Therapeutic Goods Administration (TGA), is undertaking a consumer level recall of the product Lida Daidaihua Slimming Capsules as it contains an undeclared pharmaceutical ingredient.
Date:   Oct 2007
Title:   Lida Daidaihua Slimming Capsules - consumer alert
Publisher:   Australian Government Department of Health and Ageing
Description:   Consumers who have purchased this product are warned not to use it and to consult a medical practitioner if they have taken it and have concerns about their health.
Date:   Oct 2007
Title:   Urgent medicine recall - Lumiracoxib (PREXIGE)
Publisher:   Australian Government Department of Health and Ageing
Description:   Urgent medicine recall notice - Lumiracoxib (PREXIGE). Patients taking Lumiracoxib should stop taking the medicine now and discuss alternative treatments with their doctor.
Date:   Aug 2007
Title:   Phenylpropanolamine
Publisher:   Australian Government Department of Health and Ageing
Description:   Australian consumers may be worried about reports that the US Food and Drug Administration was taking steps to remove phenylpropanolamine from all drug products. In Australia, substantial action to limit the availability of many of the products of concern to the US FDA was taken in 1983.
Date:   Mar 2006
Title:   Medicine recall - Aloe Vera Aloe Vera Jelly, Nature's Fruit Aloe Vera Cr?me Plus, Aloe Vera After Sun Soothing Spray
Publisher:   Australian Government Department of Health and Ageing
Description:   Medicine recall notice - Aloe Vera Aloe Vera Jelly, Nature's Fruit Aloe Vera Creme Plus, Aloe Vera After Sun Soothing Spray
Date:   Jan 2006
Title:   Kava fact sheet - April 2005
Publisher:   Australian Government Department of Health and Ageing
Description:   Since 2001, the Therapeutic Goods Administration (TGA) has closely followed mounting international concerns over reports of hepatotoxicity and deaths from liver failure associated with taking some kava-containing medicines.
Date:   Apr 2005
Title:   Medicine recall - Vioxx (Rofecoxib)
Publisher:   Australian Government Department of Health and Ageing
Description:   Medicine recall notice - Vioxx (Rofecoxib)
Date:   Oct 2004
Title:   Media release - TGA recalls potentially unsafe eye drops
Publisher:   Australian Government Department of Health and Ageing
Description:   Australia's medicines watchdog, the Therapeutic Goods Administration (TGA), has ordered a consumer level recall of an over the counter eye drop following spot checks by the TGA of the safety of eye drops in the market place picked up safety concerns with Eye-Lite Eye Drops, manufactured in Switzerland.
Date:   Sep 2004
Title:   Medicine recall - Mavala Eyelite eye drops
Publisher:   Australian Government Department of Health and Ageing
Description:   Medicine recall notice - Mavala Eyelite eye drops
Date:   Sep 2004
Title:   Media release - TGA alert on a consumer level recall of a complementary medicine - Nature's Own Zinc + B6 Magnesium
Publisher:   Australian Government Department of Health and Ageing
Description:   Australia's medicines regulator, the Therapeutic Goods Administration (TGA), advises consumers that Mayne Consumer Products is conducting a consumer level recall of some batches of its product Nature's Own Zinc + B6 Magnesium.
Date:   May 2004
Title:   Pan Pharmaceuticals Limited - Regulatory action and product recall information
Publisher:   Australian Government Department of Health and Ageing
Description:   The Therapeutic Goods Administration (TGA) has suspended the licence held by Pan Pharmaceuticals Limited of Sydney to manufacture medicines, for a period of six months with effect 28 April 2003, because of serious concerns about the quality and safety of products manufactured by the company.
Date:   Dec 2003
Title:   Information for sponsors: Safety of kava-containing medicines
Publisher:   Australian Government Department of Health and Ageing
Description:   The Therapeutic Goods Administration (TGA) has viewed with increasing concern international reports of liver damage (hepatotoxicity) associated with the use of kava-containing medicines. The TGA believes that, as a precaution, a voluntary recall to consumer level of all medicines containing kava on sale in Australia should commence immediately.
Date:   Aug 2002
Title:   It's natural so it must be safe (Editorial)
Publisher:   Australian Prescriber
Description:   Many complementary medicines have a long history of traditional use, and are generally regarded as safe. That is why they are sold through a range of outlets, often without the need for the advice of a health professional. Does this mean that we can make a clear distinction between poisons and medicines, and uncritically accept the mantra 'natural = safe'?
Date:   Jun 2002
Title:   Withdrawal of Cerivastatin
Publisher:   Australian Government Department of Health and Ageing
Description:   Information for Australians on the withdrawal of cerivastatin
Date:   Aug 2001
Results 1 to 19 displayed.

  • Other Related Topics: